GPX4 and cancer: Even as metabolic cell death therapies circumvent traditional apoptosis resistance, tumors develop new resistance mechanisms, as cancer cells adapt metabolism/stress responses to select for cells upregulating defenses against ferroptosis, cuproptosis, etc. For ferroptosis, some cancer cells remain viable post-GPX4 inhibition via parallel rescue systems [86].